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could be involved in this phenotype in an as yet un-
known way.
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INTRODUCTION
Previous studies undertaken by our group, identified
and characterized twelve families affected with Diffuse
Idiopathic Skeletal Hyperostosis (DISH, MIM 106400)
and/or Calcium Pyrophosphate Dihydrate (CPPD)
Chondrocalcinosis (CC), hereafter designated,
DISH/CC. DISH/CC is a poorly understood phenotype
characterised by peripheral and axial enthesopathic cal-
cifications, frequently fulfilling the radiological criteria
for DISH, and in some cases associated with CPPD
Chondrocalcinosis. A common pathogenic mechanism,
shared by the two conditions, has been suggested1.
DISH is a common skeletal disorder characterized by
progressive calcification and ossification of ligaments
and entheses2-3. The exact prevalence and incidence of
DISH is unknown, however it is well known that it is
more frequent in males and its prevalence rapidly in-
creases with age, mainly affecting subjects over the age
of 404. The prevalence of DISH in patients over 50 years
of age is 25% in males and 15% in females,5 and this
disease is now becoming a serious problem in aging so-
cieties. Several lines of evidence suggest that genetic
factors might play a part in the etiology of DISH, such
as the existence of familial cases with early onset (in the
third decade of life)6 and the higher frequency of DISH
in the boxer dogs relative to other dog breeds7-8. So far,
however, no single gene has been conclusively associa -
ted with the disease. Chondrocalcinosis is characteri -
zed by deposition of crystals of calcium pyrophosphate
dihydrate (CPPD) in articular hyaline and fibro-carti-
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ABSTRACT
Objectives: DISH/CC is a poorly understood pheno-
type characterised by peripheral and axial entheso-
pathic calcifications, frequently fulfilling the radiolog-
ical criteria for Diffuse Idiopathic Skeletal Hyperostosis
(DISH, MIM 106400), and in some cases associated
with Calcium Pyrophosphate Dihydrate (CPPD) Chon-
drocalcinosis (CC). The concurrence of DISH and CC
suggests a shared pathogenic mechanism. In order to
identify genetic variants for susceptibility we performed
whole exome sequencing in four patients showing this
phenotype.
Materials and methods: Exome data were filtered in
order to find a variant or a group of variants that could
be associated with the DISH/CC phenotype. Variants
of interest were subsequently confirmed by Sanger se-
quencing. Selected variants were screened in a cohort
of 65 DISH/CC patients vs 118 controls from Azores.
The statistical analysis was performed using PLINK
V1.07.
Results:We identified 21 genetic variants in 17 genes
that were directly or indirectly related to mineraliza-
tion, several are predicted to have a strong effect at a
protein level. Phylogenetic analysis of altered amino
acids indicates that these are either highly conserved
in vertebrates or conserved in mammals. In case-con-
trol analyses, variant rs34473884 in PPP2R2D was sig-
nificantly associated with the DISH/CC phenotype
(p=0.028; OR=1.789, 95% CI= 1.060 - 3.021)).
Conclusion: The results of the present and preceding
studies with the DISH/CC families suggests that the
phenotype has a polygenic basis. The PPP2R2D gene
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lage9. For the moment two genes, ANKH (CCAL2) and
TNFRSF11B, are known to be involved in the devel-
opment of Chondrocalcinosis10-11. Previously, we per-
formed genetic studies of DISH/CC using a “Whole
genome wide linkage study” and an “Identity by
State/Identity by Descent” association study and two
genes were identified as good candidate genes for
DISH/CC; RSPO4 on chromosome 20, and LEMD3 on
chromosome 12. Several RSPO4 gene variants were
identified and nucleotide modifications located in the
regulatory region were more frequent in control indi-
viduals than in the DISH/CC group12. Even though the
genetic basis of DISH/CC is unknown, it is considered
to be a bone forming disease and genes related to cal-
cification and ossification are considered good candi-
dates. In the present study, we took advantage of whole
exome sequencing (WES) so that even in the absence
of sufficient pedigrees and samples for traditional link-
age approaches we could identify rare protein-coding
variants that are the cause of the majority of mono-
genic diseases13-14. We performed targeted exome se-
quencing on four DISH/CC patients, with an appar-
ently autosomal dominant DISH/CC phenotype, in
order to capture rare and pathogenic variants expect-
ed to have potentially damaging effects on protein
function that lead to modified calcification and/or os-
sification. To our knowledge this is the first report of
WES analysis in patients affected with DISH.
MATERIAlS AND METHODS
This study was approved by the “Comissão de Ética
do Hospital de Santo Espírito da Ilha Terceira”. All
methods were performed in accordance with the ap-
proved guidelines, obtaining informed consent from
each subject before conducting the experiments.
ExOME CApTURE 
The selection of patients was made after ruling out mu-
tations in ANKH and secondary causes for Chondro-
calcinosis. DNA was extracted from peripheral blood
samples using a standard salting out procedure. Sam-
ples were resequenced, using an ABI-SOLiD platform
and Agilent’s SureSelect Target Enrichment System for
38 Mb, by “Sistemas Genómicos, S.L.” in Valencia,
Spain. After standard DNA quality control, SOLiD
Fragment libraries were prepared and enriched with
SureSelect All Human Enrichment Target Exon. The
quality and quantity of the libraries were assessed by
analysis with an Agilent 2100 Bioanalyzer and Qubit.
Each library went through a process of emulsion PCR
for clonal amplification of the fragments, followed by
an enrichment process and chemical modification to
allow loading into the reaction chamber. The quality
and quantity of the beads obtained for each library
were estimated taking into account the parameters giv-
en by Work Flow Analysis. Then, ligation sequencing
was done to obtain sequences of 50nt +35nt (Paired-
end) reads using a SOLiD4 sequencer. The data qual-
ity was estimated using the parameters provided by
the software SETS (SOLiD Experimental Tracking Sys-
tem). Single Nucleotide Variants (SNVs) were classified
using Ensembl’s nomenclature and grouped using the
following scheme: Known and Novel (Coding, Splic-
ing, Others). The coding variants were divided into
nonsynonymous and synonymous. The “Others” in-
cluded intronic, UTR, regulatory region, intergenic,
downstream and upstream variants. 
WES fIlTERINg 
The segregation analysis of these families indicated that
the most likely model for this disease is an autosomal
dominant model1.  However, given that a previous
linkage study did not identify a major dominant lo-
cus, the data were analyzed assuming both a recessive
and a dominant model.
Genetic variants were identified in 815, 917, 872
and 593 genes under a dominant model, for indivi -
duals AZ1 to AZ4. Assuming that the genetic cause is
the same for the individuals AZ1 to AZ4, identified
genes were then filtered to select common, shared
genes (supplementary Table I, available in supple-
mentary file). A group of 52 genes were common to the
four patients; candidate genes for testing were select-
ed taking into account their involvement in calcifica-
tion and/or ossification or related conditions that could
be associated with the DISH/CC disease. Gene vari-
ants shared between the genes common to the four pa-
tients were identified and nonsynonymous, splice site,
stop lost/gain and frameshift variants were targeted, in
anticipation that synonymous and intronic variants
would be far less likely to be relevant in the
pathogenicity. 
CANDIDATE gENES – SElECTION By fUNCTION
A group of 20 candidate genes was selected and in-
cluded genes that are reported to be involved in bone
metabolism and/or related conditions. These genes
were Alkaline Phosphatase (ALPL/TNAP), the Calcium



















































































































































































































































































































































































































































































































































































































































































































































Sensing Receptor (CASR), Bone Morphogenetic
Protein Receptor Type 1B (BMPR1B), Osteopon-
tin (OPN/SPP1), Integrin Binding Sialoprotein
(IBSP), Fibroblast Growth Factor 2 (FGF2), Inor-
ganic Pyrophosphate Transport Regulator
(ANKH), Collagen Type XI Alpha 2 (COL11A2),
Nucleotide Pyrophosphatase 1 (ENPP1), Runt-
related Transcription Factor (RUNX2), Dickkopf
WNT Signaling Pathway (DKK-1), Insulin Like
Growth Factor 1 (IGF1), Matrix Gla Protein
(MGP); Vitamin D (VDR), Bone Morphogenetic
Protein 4 (BMP-4), Collagen Type 1 Alpha 1
(COL1A1), Transforming Growth Factor Beta 1
(TGF 1), Solute Carrier Family 29 Member 1
(SLC29A1), Bone Morphogenetic Protein 2 (BMP-
-2) and Collagen Type VI Alpha 1 (COL6A1). 
gENETIC vARIANTS – SElECTION By
pATHOgENICITy
In the selection by variant pathogenicity filter-
ing strategy we used two levels; a “variant level”
and a “knowledge level” (Figure 1). In the “vari-
ant level” we first filtered according to variant
type and focused on functional significance
(splice sites, frameshift coding, nonsynonymous
coding and loss or a gain of a stop). Only the
SIFT prediction with Deleterious and Unknown
and GERP values equal or higher than 3 were in-
cluded. We excluded variants with MAF values
higher than 0.05 by filtering the SNP_IDs (rs
number or chromosome position) against the
Ensemble Variant Effect Predictor tool
(http://www.ensembl.org/ info/docs/tools/vep/
index.html). Then in the selection by “knowl-
edge” we focused only on genes associated with
calcification and/or ossification or related con-
ditions. Lastly, we evaluated the functional sig-
nificance and pathogenic potential of each vari-
ant found in the selected genes.
EvAlUATION Of gENES AND vAlIDATION Of
vARIANTS 
Information about candidate genes was obtained
from several databases, including Ensembl
(http://www.ensembl.org/index), National Center
for Biotechnology Information (NCBI) (http://
www.ncbi.nih.gov), Pubmed (https:// www.ncbi.
nlm.nih.gov/pubmedwe), GeneCards (http://
www.genecards.org/), Online Mendelian Inheri-
tance in Man (OMIM) (http://www. omim.org/)
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and MalaCards (http://www.malacards.org/).
PCR primers were designed using the software
Primer3 (http://www.bioinformatics.nl/cgi-bin/
primer3plus/primer3plus.cgi) to amplify and validate
variants detected by exome sequencing. Sanger se-
quencing using standard protocols was performed us-
ing an automated DNA sequencer ABI 3130xl (Applied
BiosystemsÒ). Genetic variants were screened using Se-
quencing Analysis and SeqScape (Applied Biosystem-
sÒ) and using a reference NCBI sequence.
The functional significance and the potential deleteri-
ous effect of each variant was explored using the follow-
ing databases: Ensembl (http://www.ensembl. org/index),
Human Gene Mutation Database (HGMD) (http://www.
hgmd.cf.ac.uk/ac/index.php) and dbSNP (https://www.
ncbi.nlm.nih.gov/projects/SNP/), ma king use of
PolyPhen-2 (Polymorphism Phenotyping v2) (http://ge-
netics.bwh.harvard.edu/pph2/), SIFT and GERP.
PolyPhen is classified as, benign [0-0.2], possibly dam-
aging [0.2-0.85], and probably damaging [0.85-1], SIFT
as deleterious if less than 0.05 and GERP, ranges from -
12.3 to 6.17, with 6.17 being the most conserved15. 
The MAF values of each variant were also analyzed.
Protein conservation analysis was performed using
ClustalW (http://www.genome.jp/tools/clustalw/) to
compare homologous amino acid sequences among
multiple vertebrates at the sites where the variations oc-
cur (accession numbers of transcripts available in sup-
plementary Table II, available in supplementary file).
fIgURE 1. The two-level filter approach used to analyze the WES results from 4 patients with DISH/CC disease. 
SIFT: Sorting Intolerant From Tolerant, GERP: Genomic Evolutionary Rate Profiling score and MAF: Minor Allele Frequency
ASSOCIATION STUDIES AND STATISTICAl 
ANAlySIS
In order to verify a possible association between iden-
tified genes from WES and the DISH/CC phenotype,
selected variants were screened in family members (af-
fected with DISH/CC and unaffected), and the most
conserved variants and those that were present in three
or four WES patients, were selected for screening in a
group of 65 DISH/CC patients and a group of 118 con-
trols. Association testing was performed by chi-squared
analysis using PLINK software (V1.07)16: p-values
<0.05 were considered significant. ORs with a 95% CI
were calculated for the minor alleles of each variant.
OR >1 indicates a susceptibility allele and OR<1 indi-
cates a protective allele for the disease.
RESUlTS
The WES was performed using DNA from four patients
from unrelated DISH/CC families (AZ1-AZ4) from
Azores. A detailed description of these families is pro-
vided in our previous study1. The patients who gave
informed consent, a blood sample was obtained and
standard X-rays were taken from: the knees, axial skele-
ton, wrists, hands, elbows, and pelvis. The 4 patients
were selected because they shared a very evident DISH
phenotype. The radiological characterization of pa-
tients selected for WES are indicated in Table I. 
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fIlTERINg RESUlTS
Approximately 38 Mb of sequence per patient was gen-
erated and the capture specificity and sensitivity in all
samples was about 55% and 94%, respectively. The re-
sults for each sample after SNV calling and indel identi-
fication steps are summarized in supplementary Table III.
After filtering, 21 missense, deletion and splice site
variants in 17 genes were obtained: PLCG2, ALPL,
CASR, FGF2, COL11A2, ENPP1, MGP, VDR, BMP-4,
COL1A1, TGF 1, BMP-2, COL6A1, FLNC, AMER3,
PPP2R2D and ABCC6. Ten of the identified variants
were present in the HGMD mutation database, linked
to phenotypes, other than DISH/CC. The identified
variants and available functional information are pre-
sented in Table II. 
Sequence conservation of the missense variants were
fIgURE 2. Sequence conservation in six vertebrates of the variants identified in candidate genes possibly associated with the DISH/CC
phenotype in humans (some genes are not available in all species). The variant for the FGF2 gene is not presented since it is located in
the 3’ untranslated region.
Abbreviations: PLCG2- Phospholipase C Gamma 2, ALPL- Alkaline Phosphatase, Liver/Bone/Kidney, CASR- calcium-sensing receptor,
COL11A2- Collagen Type XI Alpha 2 Chain, ENPP1– ectonucleotide pyrophosphatase/phosphodiesterase 1, MGP- Matrix Gla Protein,
VDR- Vitamin D Receptor, BMP4- Bone morphogenetic protein 4, COL1A1- Collagen Type I Alpha 1 Chain, BMP2- Bone morphogenetic
protein 2, COL6A1- Collagen Type VI Alpha 1 Chain, FLNC- Filamin C, AMER3- APC Membrane Recruitment Protein 3, PPP2R2D-
Protein Phosphatase 2 Regulatory Subunit B delta, ABCC6 – ATP-binding cassete subfamily C, member 6.
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then evaluated in 6 different vertebrates. It is evident
in Figure 2 that the variants in the genes PPP2R2D,
BMP2, FLNC, and CASR are highly conserved in all the
vertebrates analyzed. Variants of the genes VDR, BMP4,
COL1A1 and ABCC6 are only conserved in mammals.
The degree of conservation is not directly linked to low-
er allele frequency, since several of these variants have
high Minor Allele Frequencies (MAF).
ASSOCIATION BETWEEN vARIANTS AND THE
DISH/CC pHENOTypE 
Two cohorts, one of 65 unrelated DISH/CC patients
(45 males, 20 females; age of onset around 40 years)
and another of 118 unrelated controls without any
signs of DISH/CC, with a similar ethnic background,
were selected after radiological characterization (47
males, 71 females; mean current age, 68 years; range,
60-104) and used for association studies. In cases we
selected younger patients around the age of 40, where
genetic factors may be associated, however in the con-
trols we selected older individuals to ensure that they
have not developed the disease.
All patients had at least 2 highly conserved genetic
variants in combination with other variants that are
normally conserved in mammals (Table II). Variants
with a high degree of conservation, present in 4 or 3
WES patients, irrespective of the MAF, were selected
for the association study. The variants rs34473884,
rs9277934 and rs2228570 in PPP2R2D, COL11A2 and
VDR genes, respectively, were present in all four WES
patients. The variants rs1048201, rs235768,
rs1044498 and rs17563 in FGF2, BMP2, ENPP1 and
BMP4 genes, respectively, were present in three of the
four patients selected for WES. Seven variants were
screened in a group of 65 DISH/CC patients and 118
controls and the results are indicated in Table III. The
variant rs34473884 in the PPP2R2D gene was the only
that gave significant results. It was found to be much
more frequent in the DISH/CC group than in the con-
trols (p=0.028; OR=1.789, 95% CI= 1.060 - 3.021).
DISCUSSION
In this study, we used WES as a method to identify can-
didate genes for DISH/CC aetiology and association
studies to investigate some of the identified variants.
As expected, thousands of protein coding variants per
patient were identified across each exome. Conse-
quently, a number of filtering strategies were used to se-
lect potential high risk variants of genes potentially as-
sociated with DISH. The filtering strategies employed
were based on previous knowledge about gene func-
tion. The major limitations of the strategy used to iden-
tify candidate genes is that unannotated genes and
those with unknown functions were not investigated in
the study.
Very few genetic studies have been published about
DISH so far. DISH susceptibility genes have previous-
ly been investigated, including Human Leukocyte Anti-
gens (HLA),17-24 Collagen 6A1 gene (COL6A1),25 Fi-
broblast Growth factor 2 (FGF2),26 Vitamin D (1,25-
Dihydroxyvitamin D3) Receptor (VDR) and Collagen
Type I 1 (COL1A1),27 but only two genes are known to
TABlE III. ASSOCIATION STUDy BETWEEN SEvEN vARIANTS fROM SEvEN gENES AND THE DISH/CC pHENOTypE
MAF
SNP Allele DISH/CC Controls 
Chr Gene M/m MAF (N=65) (N=118) OR (95% CI) p-value
10 PPP2R2D rs34473884 G/A 0.262 0.165 1.789 (1.060 - 3.021) 0.028
14 BMP4 rs17563 T/C 0.454 0.390 1.301 (0.843 - 2.006) 0.234
4 FGF2 rs1048201 C/T 0.139 0.131 1.063 (0.569 - 1.985) 0.849
6 ENPP1 rs1044498 A/C 0.200 0.203 0.979 (0.574 - 1.670) 0.938
6 COL11A2 rs9277934 G/A 0.385 0.360 1.110 (0.713 - 1.728) 0.643
20 BMP2 rs235768 A/T 0.292 0.284 1.042 (0.650 - 1.671) 0.865
12 VDR rs2228570 T/C 0.400 0.373 1.121 (0.723 - 1.739) 0.609
The minor alleles are indicated in bold.
Abbreviations: Chr: Chromossome, SNP: Single nucleotide polymorphism, M/m: major allele/minor allele, MAF: Minor allele frequency and
OR (95% CI): Odds Ratio (95% Confidence Interval).
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have a positive association with DISH susceptibility;
COL6A128-29 and FGF2.26 However, the COL6A1 and
FGF2 variants associated with the disease, are located
in non-coding regions and are common variants with-
in the general population, suggesting they have a small
genetic effect. 
In our study we found 3 genetic variants that were
present in all 4 DISH/CC patients and 6 that were pre-
sent in 3 DISH/CC patients. Minor allele frequencies of
these variants were high (mean 0.25), meaning that
these were common variants in the general population.
Rare nonsynonymous SNPs are two times more likely
to be predicted as protein-affecting, when compared to
common SNPs. However, in our study three common
SNPs, shared by the 4 patients (G358S, E276K and
M1T in PPP2R2D, COL11A2 and VDR genes, respecti -
vely), according to SIFT and/or PolyPhen algorithms
were predicted to have a strong effect on the protein.
Eight of these genetic variants, in heterozygous and/or
homozygous states, were in conserved positions of pro-
teins associated with mineralization; four of which were
in regions that were highly conserved across the verte-
brates. The four WES selected patients had at least 2
highly conserved genetic variants in combination with
other variants that were conserved in mammals. The as-
sociation study indicated that the SNP rs34473884 in
the PPP2R2D gene was significantly associated with the
DISH/CC phenotype. 
In humans, the full PPP2R2D (Protein Phosphatase
2 Regulatory Subunit   delta) gene structure is com-
posed of 9 exons and spans 79.19 kb in chromosome
10. The gene encodes a crucial serine/threonine protein
phosphatase that regulates basal cellular activities by
dephosphorylating substrates. Protein Ser/Thr phos-
phatases are a group of enzymes that catalyze the re-
moval of phosphate groups from serine and/or threo-
nine residues by hydrolysis of phosphoric acid
monoesters. They oppose the action of kinases and
phosphorylases and are involved in signal transduc-
tion. Protein phosphatases have long been postulated
to influence TGF-  superfamily signaling, which regu-
lates numerous cellular responses30. Despite the long-
standing suspected influence of protein phosphatases
in TGF-  signaling, concrete data confirming the inter-
action only started to emerge recently. In human cell
lines, PPP2R2D negatively modulates TGF- /Activin/
/Nodal signaling by inhibiting the type I receptors
ALK4 and ALK531. 
The variant c.1072G>A (G327S) found in PPP2R2D
gene is a missense variant which causes substitution of
glycine for serine at amino acid 327 in the protein.
These two amino acids are hydrophilic but glycine is
non-polar and serine is polar. The glycine is normally
totally conserved in all vertebrates studied, and the
variant has a low, deleterious, SIFT score (0.03) but the
Polyphen score (0.33) does not corroborate its harm-
ful effect. The frequency of this variant is high in Eu-
ropean populations with a MAF of 0.18 and this vari-
ant was identified in all four DISH/CC patients used
for WES; AZ1 was homozygous and AZ2, 3 and 4 were
heterozygous. As far as we known no phenotype has
been associated with this gene. 
Rare variants, with a deleterious effect on proteins in
the human genome, are the basis for the development
of Mendelian diseases. However, common polymor-
phisms that individually exert small effects might, as a
group, also play a substantial genetic role. Despite the
lack of association of most of the studied gene variants
in the present study, this may be in part linked to the
heterogeneous features of the phenotype, and so im-
proved characterization of the disorder under study is
essential for the planning of future studies. The results
of our study lead us to suggest that DISH/CC is poly-
genic, and is influenced by the interaction of multiple,
small effect gene variants and possibly by unknown en-
vironmental factors.
CONClUSION
Our results underline the polygenic nature of DISH and
a number of conserved and sometimes deleterious vari-
ants were identified in genes with a role in mineraliza-
tion. The variant rs34473884 in the PPP2R2D gene was
significantly associated with the DISH/CC phenotype
and we propose it may contribute to the development
of this disorder. Further studies will be needed to con-
firm the association of PPP2R2D with the phenotype
under study.
ACkNOWlEDgEMENTS
The authors thank all the patients who participated in this research
and made it possible. We also thank Isa Dutra (MSc), João Paulo
Pinheiro (BsC) and Raquel Meneses (BsC) from Hospital Santo Es-
pírito da Ilha Terceira, EPE, Epidemiology and Molecular Biology
Service (SEEBMO), Angra do Heroísmo, Portugal, who performed
the DNA extractions and Vânia Machado (MSc), who participated
in the elaboration of the pedigrees. BP was supported by “Fundo Re-
gional para a Ciência e Tecnologia (FRCT)” (M3.1.2/F/023/2011).
COMpETINg fINANCIAl INTERESTS
The authors declare no competing interests.





Serviço Especializado de Epidemiologia e Biologia Molecular 
(SEEBMO) 
Hospital de Santo Espírito da Ilha Terceira (HSEIT)
Canada do Briado
9700-049, Angra do Heroísmo
E-mail: brugesarmas@gmail.com
REfERENCES
1. Bruges-Armas J, Couto AR, Timms A, Santos MR, Bettencourt
BF, Peixoto MJ, et al. Ectopic calcification among families in the
Azores: clinical and radiologic manifestations in families with
diffuse idiopathic skeletal hyperostosis and chondrocalcinosis.
Arthritis Rheum 2006; 54: 1340-1349.
2. Mader R. Clinical manifestations of diffuse idiopathic skeletal
hyperostosis of the cervical spine. Sem Arthritis Rheum 2002;
32: 130-135.
3. Mader R, Verlaan JJ, Buskila D. Diffuse idiopathic skeletal hy-
perostosis: clinical features and pathogenic mechanisms. Nat
Rev Rheumatol 2013; 9: 741-750.
4. Utsinger PD. Diffuse Idiopathic Skeletal Hyperostosis. Clin
Rheum Dis 1985; 11: 325-351.
5. Weinfeld RM, Olson PN, Maki DD, Griffiths HJ. The prevalence
of diffuse idiopathic skeletal hyperostosis (DISH) in two large
American Midwest metropolitan hospital populations. Skeletal
Radiol 1997; 26: 222-225.
6. Beardwell A. Familial Ankylosing Vertebral Hyperostosis With
Tylosis. Ann Rheum Dis 1969; 28: 518-523.
7. Woodard JC, Poulos PW, Jr., Parker RB, Jackson RI, Jr., Eurell
JC. Canine diffuse idiopathic skeletal hyperostosis. Vet Pathol
1985; 22: 317-326.
8. Morgan J, Stavenborn M. Disseminated idiopathic skeletal hy-
perostosis (DISH) in a dog. Vet Radiol Ultrasound 1991; 32:
65-70.
9. Gutierrez M, Silveri F, Bertolazzi C, Giacchetti G, Tardella M, Di
Geso L, et al. [Gitelman syndrome associated with chondrocal-
cinosis: description of two cases]. Reumatismo 2010; 62: 60-64.
10. Netter P, Bardin T, Bianchi A, Richette P, Loeuille D. The ANKH
gene and familial calcium pyrophosphate dihydrate deposition
disease. Joint Bone Spine 2004; 71: 365-368.
11. Ramos YF, Bos SD, van der Breggen R, Kloppenburg M, Ye K,
Lameijer EW, et al. A gain of function mutation in TNFRSF11B
encoding osteoprotegerin causes osteoarthritis with chondro-
calcinosis. Ann Rheum Dis 2015; 74: 1756-62.
12. Couto AR, Parreira B, Thomson R, Soares M, Power DM,
Stankovich J, et al. Combined approach for finding suscepti-
bility genes in DISH/chondrocalcinosis families: whole-genome-
wide linkage and IBS/IBD studies. Hum Genome Var 2017; 4:
17041.
13. Ng SB, Buckingham KJ, Lee C, Bigham AW, Tabor HK, Dent
KM, et al. Exome sequencing identifies the cause of a mendelian
disorder. Nat Genet 2010; 42: 30-35.
14. Rabbani B, Tekin M, Mahdieh N. The promise of whole-exome
sequencing in medical genetics. J Hum Genet 2014; 59: 5-15.
15. Cooper GM, Stone EA, Asimenos G, Green ED, Batzoglou S,
Sidow A. Distribution and intensity of constraint in mammalian
genomic sequence. Genome Res 2005; 15: 901-913.
16. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Ben-
der D, et al. PLINK: a tool set for whole-genome association and
population-based linkage analyses. Am J Hum Genet 2007; 81:
559-575.
17. Rosenthal M, Bahous I, Müller W. Letter: HL-A B27 and modi-
fied bone formation. Lancet 1976 1: 543.
18. Rotés Querol J, Ercilla González G. Letter: HLA-B27 and mod-
ified bone formation. Lancet 1976 1: 482-3.
19. Brigode M, Francois RJ. Histocompatibility antigens in vertebral
ankylosing hyperostosis. J Rheumatol 1977 4: 429-434.
20. Spagnola AM, Bennett PH, Terasaki PI. Vertebral ankylosing hy-
perostosis (Forestier's disease) and HLA antigens in Pima Indi-
ans. Arthritis Rheum 1978 21: 467-72.
21. Perry JD, Wolf H, Festenstein H, Storey GO. Ankylosing hy-
perostosis: a study of HLA A, B, and C antigens. Ann Rheum Dis
1979 38: 72-73.
22. Dostál C, Ivasková E, Hána I, Sváb V. HLA antigens in vertebral
ankylosing hyperostosis (Forestier's disease). J Hyg Epidemiol
Microbiol Immunol 1983; 27: 98-102.
23. Rosenthal M, Bahous I, Muller W. Increased frequency of HLA
B8 in hyperostotic spondylosis. J Rheumatol Suppl 1977; 3: 94-
-96.
24. Ercilla González G, Brancós MA, Breisse Y. Histocompatability
antigens in Forestier's disease, polyarthrosis and ankylosing
spondylitis.  HLA and Disease. Paris: INSERM; 1976. p. 28.
25. Tsukahara S, Miyazawa N, Akagawa H, Forejtova S, Pavelka K,
Tanaka T, et al. COL6A1, the candidate gene for ossification of
the posterior longitudinal ligament, is associated with diffuse id-
iopathic skeletal hyperostosis in Japanese. Spine 2005 30: 2321-
-2324.
26. Jun JK, Kim SM. Association study of fibroblast growth factor 2
and fibroblast growth factor receptors gene polymorphism in
korean ossification of the posterior longitudinal ligament pa-
tients. J Korean Neurosurg Soc 2012; 52: 7-13.
27. Havelka S, Uitterlinden AG, Fang Y, Arp PP, Pavelková A, Veselá
M, et al. Collagen type I(alpha 1) and vitamin D receptor poly-
morphisms in diffuse idiopathic skeletal hyperostosis. Clin
Rheumatol 2002 21: 347-348.
28. Tanaka T, Ikari K, Furushima K, Okada A, Tanaka H, Furukawa
K, et al. Genomewide linkage and linkage disequilibrium anal-
yses identify COL6A1, on chromosome 21, as the locus for os-
sification of the posterior longitudinal ligament of the spine.
Am J Hum Genet 2003; 73: 812-822.
29. Kong Q, Ma X, Li F, Guo Z, Qi Q, Li W, et al. COL6A1 poly-
morphisms associated with ossification of the ligamentum
flavum and ossification of the posterior longitudinal ligament.
Spine (Phila Pa 1976) 2007; 32: 2834-2838.
30. Liu T, Feng XH. Regulation of TGF-beta signalling by protein
phosphatases. Biochem J 2010; 430: 191-198.
31. Batut J, Schmierer B, Cao J, Raftery LA, Hill CS, Howell M. Two
highly related regulatory subunits of PP2A exert opposite ef-
fects on TGF-beta/Activin/Nodal signalling. Development 2008;
135: 2927-2937.
ÓRgÃO OfICIAL dA SOCIEdAdE PORTUgUESA dE REUMATOLOgIA
125
PARREIRA B ET AL
SUpplEMENTARy fIlES
SUpplEMENTARy TABlE I. NUMBER Of 
CANDIDATE gENES pER SAMplE AND NUMBER




































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































ÓRgÃO OfICIAL dA SOCIEdAdE PORTUgUESA dE REUMATOLOgIA
126
EcToPIc cALcIfIcATIon
SUpplEMENTARy TABlE III. kNOWN, NOvEl AND TOTAl NUMBER Of SNvS AND INDElS fOR THE fOUR 
SAMplES TESTED (AZ1-4)
SNVs Indels TOTAL/
Sample Known Novel Total Known Novel Complex Total sample
AZ1 17281 1619 18900 457 405 51 913 19813
AZ2 18086 1759 19845 440 496 66 1002 20847
AZ3 18327 1650 19977 524 505 73 1102 21079
AZ4 17575 1223 18798 475 424 72 971 19769
SNVs: Single nucleotide variants.
